SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Synaptic Pharmaceutical Corporation
(Name of Issuer)
Common Stock, Par Value $.01 Per Share
(Title of Class of Securities)
87156 R 109
(CUSIP Number)
Check the following box if a fee is being paid with this
statement [x]. (A fee is not required only if the filing person: (1)
has a previous statement on file reporting beneficial ownership of
more than five percent of the class of securities described in Item 1;
and (2) has filed no amendment subsequent thereto reporting beneficial
ownership of less than five percent of such class.) (See Rule 13d-7.)
* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a
prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
Page 1 of 5 pages
<PAGE>
CUSIP No. 87156 R 109 Page 2 of 5 pages
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Ciba-Geigy Limited
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Switzerland
5 SOLE VOTING POWER
535,715
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 0
OWNED BY
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 535,715
PERSON WITH
8 SHARED DISPOSITIVE POWER
0
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
535,715
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
11 PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.5%
12 TYPE OF REPORTING PERSON
CO
<PAGE>
Item 1(a). Name of Issuer:
This Statement on Schedule 13G relates to the common stock, par
value $.01 per share (the "Common Stock"), of Synaptic Pharmaceutical
Corporation, a Delaware corporation ("Synaptic").
Item 2(a). Name of Person Filing:
Ciba-Geigy Limited.
Item 2(b). Address of Principal Business Office:
141 Klybeckstrasse, CH-4002 Basle, Switzerland
Item 2(c). Citizenship:
Ciba-Geigy Limited is a Swiss corporation.
Item 2(d). Title of Class of Securities.
Common stock, par value $.01 per share, of Synaptic.
Item 2(e). CUSIP Number:
87156 R 109
Item 3. If this Statement is Filed Pursuant to Rules 13d-(b), or
13D-2(b), Check Whether the Person Filing is a:
Not applicable.
Item 4. Ownership.
(a) Amount Beneficially Owned: 535,715 shares of Common Stock.
(b) Percent of Class: 9.5%
Page 3 of 5
<PAGE>
(c) Number of Shares as to Which Ciba-Geigy Limited has:
(i) sole power to vote or to direct the vote:
535,715
(ii) shared power to vote or to direct the vote:
Zero
(iii) sole power to dispose or to direct the
disposition of: 535,715
(iv) shared power to dispose or to direct the
disposition of: Zero
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
Not applicable.
Page 4 of 5
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this Statement is
true, complete and correct.
Date: February 13, 1996
CIBA-GEIGY LIMITED
By: /s/ Dr. Herbert Gut
-------------------------
Name: Dr. Herbert Gut
Title: Senior Division Counsel
/s/ Robin Walker
-------------------------
Name: Robin Walker
Title: Division Counsel
Page 5 of 5
